-
1
-
-
67349143664
-
European best practice guidelines for cystic fibrosis neonatal screening
-
Castellani C., Southern K.W., Brownlee K., et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros 2009, 8:153-173.
-
(2009)
J Cyst Fibros
, vol.8
, pp. 153-173
-
-
Castellani, C.1
Southern, K.W.2
Brownlee, K.3
-
2
-
-
68049096166
-
Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis
-
Goubau C., Wilschanski M., Skalická V., et al. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis. Thorax 2009, 64:683-691.
-
(2009)
Thorax
, vol.64
, pp. 683-691
-
-
Goubau, C.1
Wilschanski, M.2
Skalická, V.3
-
3
-
-
70449657523
-
EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates
-
Hogardt M., Ulrich J., Riehn-Kopp H., Tümmler B. EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates. J Clin Microbiol 2009, 47:3435-3438.
-
(2009)
J Clin Microbiol
, vol.47
, pp. 3435-3438
-
-
Hogardt, M.1
Ulrich, J.2
Riehn-Kopp, H.3
Tümmler, B.4
-
4
-
-
77249176209
-
Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date
-
Becq F. Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date. Drugs 2010, 70:241-259.
-
(2010)
Drugs
, vol.70
, pp. 241-259
-
-
Becq, F.1
-
5
-
-
33751239440
-
Cellular and animal models of cystic fibrosis, tools for drug discovery
-
Scholte B.J., Colledge W.H., Wilke M., de Jonge H. Cellular and animal models of cystic fibrosis, tools for drug discovery. Drug Discov Today Dis Models. 2006, 3:251-259.
-
(2006)
Drug Discov Today Dis Models.
, vol.3
, pp. 251-259
-
-
Scholte, B.J.1
Colledge, W.H.2
Wilke, M.3
de Jonge, H.4
-
6
-
-
69049093870
-
Ethical principles and legal requirements for pediatric research in the EU: an analysis of the European normative and legal framework surrounding pediatric clinical trials
-
Pinxten W., Dierickx K., Nys H. Ethical principles and legal requirements for pediatric research in the EU: an analysis of the European normative and legal framework surrounding pediatric clinical trials. Eur J Pediatr 2009, 168:1225-1234.
-
(2009)
Eur J Pediatr
, vol.168
, pp. 1225-1234
-
-
Pinxten, W.1
Dierickx, K.2
Nys, H.3
-
7
-
-
78649908972
-
European Registry Working Group. Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries
-
(this issue)
-
Mehta G., Macek M., Mehta A. European Registry Working Group. Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. J Cyst Fibros 2010, 9:S5-S21. (this issue).
-
(2010)
J Cyst Fibros
, vol.9
-
-
Mehta, G.1
Macek, M.2
Mehta, A.3
-
8
-
-
78649907417
-
Commentary
-
(this issue)
-
Fahy N. Commentary. J Cyst Fibros 2010, 9:S3-S4. (this issue).
-
(2010)
J Cyst Fibros
, vol.9
-
-
Fahy, N.1
-
9
-
-
77949728437
-
Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis
-
European Registry Working Group
-
McCormick J., Mehta G., Olesen H.V., Viviani L., Macek M., Mehta A. Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet 2010, 375:1007-1013. European Registry Working Group.
-
(2010)
Lancet
, vol.375
, pp. 1007-1013
-
-
McCormick, J.1
Mehta, G.2
Olesen, H.V.3
Viviani, L.4
Macek, M.5
Mehta, A.6
-
10
-
-
78649904350
-
Guideline on the design and conduct of CF clinical trials: the European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN)
-
(Second EuroCareCF Supplement).
-
De Boeck K., Bulteel V., Tiddens H., et al. Guideline on the design and conduct of CF clinical trials: the European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN). J Cyst Fibros 2010, (Second EuroCareCF Supplement).
-
(2010)
J Cyst Fibros
-
-
De Boeck, K.1
Bulteel, V.2
Tiddens, H.3
|